Immunopathy is a broad medical term for any disease or disorder caused by a malfunction of the immune system. Rather than describing a single condition, it covers a wide spectrum: the immune system might be overactive, attacking the body’s own tissues; underactive, leaving you vulnerable to infections; or dysregulated in a way that leads to uncontrolled cell growth. Roughly 8% to 10% of the world’s population is affected by autoimmune diseases alone, and that prevalence nearly doubled between 1990 and 2021.
The Four Categories of Immune Dysfunction
Immunopathies generally fall into four groups, each reflecting a different way the immune system goes wrong.
- Hypersensitivity: The immune system overreacts to a substance that is normally harmless (like pollen) or mounts a disproportionate response to a real threat, damaging healthy tissue in the process.
- Autoimmunity: The immune system mistakes the body’s own cells for invaders and attacks them. Lupus, rheumatoid arthritis, and type 1 diabetes are classic examples.
- Immunodeficiency: The immune system is too weak or incomplete to fight infections effectively. This can be genetic (primary) or acquired later in life (secondary).
- Immunoproliferative disorders: Immune cells, particularly white blood cells called lymphocytes, multiply out of control. This category includes certain leukemias and lymphomas.
These categories overlap more than they might appear to. Someone with an immunoproliferative disorder, for example, often develops immunodeficiency because the flood of abnormal immune cells crowds out functioning ones. And certain immunodeficiencies raise the risk of autoimmune disease.
Hypersensitivity: When the Immune System Overreacts
Hypersensitivity reactions are classified into four types, originally described by immunologists Philip Gell and Robin Coombs. Type I is the immediate allergic reaction most people recognize: hives, anaphylaxis, hay fever. It happens within minutes of exposure to an allergen.
Type II reactions occur when antibodies latch onto the surface of the body’s own cells and mark them for destruction. The immune system then attacks those tagged cells through several routes: assembling a protein complex that punches holes in cell membranes, flagging cells so that scavenger cells engulf them, or recruiting natural killer cells that release enzymes to trigger cell death. This mechanism drives conditions like autoimmune hemolytic anemia (where red blood cells are destroyed), immune-related low platelet counts, and transfusion reactions.
Type III reactions involve clumps of antibodies and antigens that deposit in tissues, triggering inflammation. Type IV reactions are delayed, appearing 48 to 72 hours after exposure. Contact dermatitis from poison ivy is a familiar example.
How the Body Normally Prevents Autoimmunity
Your immune system is trained early in life to distinguish your own cells from foreign invaders. This training happens through two main processes. First, immature immune cells that react strongly to the body’s own proteins are eliminated before they mature, a process called clonal deletion. Second, immune cells that slip past this checkpoint but encounter the body’s proteins without the right activation signals become functionally silenced, unable to mount an attack.
Some self-proteins exist at such low levels that the immune system simply never notices them. This state of “immunological ignorance” is normally harmless. But when something disrupts these safeguards, previously ignored proteins can become targets. Autoimmune diseases like type 1 diabetes and Hashimoto’s thyroiditis don’t usually reflect a wholesale collapse of tolerance. Instead, a narrow failure allows immune cells to attack one specific organ while the rest of the system functions normally. Certain signaling molecules, particularly an anti-inflammatory protein called TGF-beta, help steer immune responses toward less destructive pathways, and disruptions in these signals can tip the balance toward tissue damage.
Immunodeficiency: Primary vs. Secondary
Primary immunodeficiencies are genetic. They’re present from birth, though symptoms may not appear until infections start accumulating in childhood or even adulthood. Common signs include pneumonia, bronchitis, sinus infections, and ear infections that keep coming back, last longer than expected, or resist standard treatment. Some people also develop blood disorders like anemia or low platelet counts, digestive problems, or delayed growth.
Secondary immunodeficiencies are far more common and develop later in life. HIV infection is the most well-known cause, but diabetes, malnutrition, chemotherapy, radiation therapy, and prolonged critical illness can all suppress immune function. Aging itself weakens the immune response, which is one reason older and hospitalized adults are especially vulnerable to infections. In many cases, secondary immunodeficiency is reversible once the underlying cause is treated. Rarely, prolonged exposure to certain environmental toxins like pesticides or benzene can also suppress immunity.
Immunoproliferative Disorders
When the mechanisms that normally keep immune cell growth in check break down, lymphocytes can multiply uncontrollably. This leads to a group of conditions called lymphoproliferative disorders, characterized by swollen lymph nodes, abnormally high lymphocyte counts in the blood, and infiltration of the bone marrow. These disorders frequently arise in people who are already immunocompromised.
Both major types of lymphocytes, B cells and T cells, can be involved. B-cell disorders include chronic lymphocytic leukemia, hairy cell leukemia, and mantle cell lymphoma. T-cell disorders include Sézary syndrome (a form of lymphoma affecting the skin) and adult T-cell leukemia-lymphoma. Because these conditions involve immune cells themselves, they often create a vicious cycle: the proliferating cells crowd out healthy ones, worsening immune dysfunction and raising the risk of serious infections.
How Immunopathies Are Diagnosed
There is no single test for immunopathy. Diagnosis typically requires a layered approach, starting with basic blood work and moving toward more specialized testing depending on which type of immune dysfunction is suspected.
A complete blood count reveals whether immune cell numbers are abnormally high or low. Inflammatory markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) indicate whether active inflammation is present. CRP levels below 0.2 mg/dL are considered normal, while levels above 1.0 mg/dL suggest ongoing inflammation or infection. In inflammatory blood vessel diseases, both CRP and ESR are often markedly elevated.
For suspected autoimmune conditions, testing for antinuclear antibodies (ANA) is a common first step. ANA testing looks for antibodies that mistakenly target components of your own cell nuclei. A positive ANA is the hallmark of lupus, but it also shows up in Sjögren’s syndrome, rheumatoid arthritis, scleroderma, and other autoimmune diseases. More specific antibody panels help narrow down which condition is responsible.
Measuring immunoglobulin levels (IgG, IgA, and IgM) in the blood is essential for evaluating immunodeficiency. These proteins reflect how well your B cells are producing antibodies. Low levels suggest the immune system can’t mount an adequate defense against infections. Flow cytometry, a technique that counts and categorizes individual immune cells, rounds out the picture by identifying exactly which cell populations are affected.
Treatment Approaches
Treatment depends entirely on which direction the immune system has gone wrong. For autoimmune diseases and hypersensitivity reactions, the goal is to dial down the immune response. Immunosuppressant medications prevent the immune system from attacking healthy cells and tissues. Corticosteroids like prednisone are among the most widely prescribed, reducing both the immune response and the inflammation that causes tissue damage. Stronger immunosuppressants are used when corticosteroids alone aren’t enough.
For immunodeficiency, the approach reverses: the goal is to boost or replace missing immune function. This can mean regular infusions of immunoglobulins to compensate for antibodies the body can’t produce, or treating the underlying condition that’s suppressing immunity. Immunoproliferative disorders are typically managed with cancer-directed therapies aimed at stopping the uncontrolled growth of immune cells.
Living with any immunopathy often means long-term monitoring. Blood tests track whether the immune system is staying in balance, medications are adjusted as the disease fluctuates, and infections or flares are caught early before they escalate.